Vaxart, Inc. (VXRT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 90M 180M 270M Q3 '16: 7.7M Q4 '16: 9.8M Q1 '17: 6.8M Q2 '17: 8.1M Q3 '17: 8.9M Q4 '17: 7.8M Q1 '18: 7M Q2 '18: 5.7M Q3 '18: 5.1M Q4 '18: 4.2M Q1 '19: 8.1M Q2 '19: 7.5M Q3 '19: 7.7M Q4 '19: 9.9M Q1 '20: 7.4M Q2 '20: 7.8M Q3 '20: 7.6M Q4 '20: 4M Q1 '21: 1.6M Q2 '21: 1.2M Q3 '21: 1.2M Q4 '21: 892K Q1 '22: 471K Q2 '22: 359K Q3 '22: 159K Q4 '22: 107K Q1 '23: 697K Q2 '23: 2.1M Q3 '23: 4.2M Q4 '23: 7.4M Q1 '24: 8.9M Q2 '24: 13.9M Q3 '24: 16.8M Q4 '24: 28.7M Q1 '25: 47.4M Q2 '25: 80.7M Q3 '25: 148.2M Q4 '25: 237.3M Q1 '26: 255.6M Q2 '26: 243.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

-45M -30M -15M 0 15M 30M 45M Q2 '13: 13.3M Q3 '13: 9.3M Q4 '13: 5.9M Q1 '14: 700K Q2 '14: -11.4M Q3 '14: -14.4M Q4 '14: -7.9M Q1 '15: -10M Q2 '15: -19.5M Q3 '15: -19.2M Q4 '15: -32.1M Q1 '16: -38.4M Q2 '16: -25.2M Q2 '13 Q4 '13 Q2 '14 Q4 '14 Q2 '15 Q4 '15 Q2 '16

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '16: -28M Q4 '16: -30.1M Q1 '17: -27.1M Q2 '17: -23.6M Q3 '17: -15.9M Q4 '17: -10.2M Q1 '18: -11.9M Q2 '18: -16.5M Q3 '18: -20.5M Q4 '18: -21.8M Q1 '19: -18.3M Q2 '19: -15.5M Q3 '19: -14.3M Q4 '19: -15.8M Q1 '20: -16M Q2 '20: -19.6M Q3 '20: -22.4M Q4 '20: -30.2M Q1 '21: -45M Q2 '21: -52.2M Q3 '21: -61.9M Q4 '21: -72.8M Q1 '22: -82M Q2 '22: -95.5M Q3 '22: -107.7M Q4 '22: -114.6M Q1 '23: -115.4M Q2 '23: -109.2M Q3 '23: -97.6M Q4 '23: -83.3M Q1 '24: -81.8M Q2 '24: -75M Q3 '24: -71.7M Q4 '24: -66.3M Q1 '25: -57.2M Q2 '25: -55.5M Q3 '25: -48.8M Q4 '25: 18.1M Q1 '26: 38.2M Q2 '26: 39.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '16: -28.8M Q4 '16: -31.4M Q1 '17: -29M Q2 '17: -25.4M Q3 '17: -17.6M Q4 '17: -11.9M Q1 '18: -6.8M Q2 '18: -12.1M Q3 '18: -16.5M Q4 '18: -18M Q1 '19: -21.7M Q2 '19: -18.4M Q3 '19: -17.1M Q4 '19: -18.6M Q1 '20: -18.6M Q2 '20: -21.9M Q3 '20: -24.8M Q4 '20: -32.2M Q1 '21: -46.9M Q2 '21: -54.1M Q3 '21: -63.6M Q4 '21: -70.5M Q1 '22: -79.6M Q2 '22: -92.9M Q3 '22: -104.6M Q4 '22: -107.8M Q1 '23: -107.8M Q2 '23: -100.9M Q3 '23: -89M Q4 '23: -82.5M Q1 '24: -81.7M Q2 '24: -75.7M Q3 '24: -72.3M Q4 '24: -66.9M Q1 '25: -58.1M Q2 '25: -56.6M Q3 '25: -50.7M Q4 '25: 16.3M Q1 '26: 37.1M Q2 '26: 38.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 30M 60M 90M Q2 '13: 20.4M Q3 '13: 35.2M Q4 '13: 46.7M Q1 '14: 68.9M Q2 '14: 80.2M Q3 '14: 71.6M Q4 '14: 60.5M Q1 '15: 39M Q2 '15: 44.1M Q3 '15: 44.8M Q4 '15: 45.5M Q1 '16: 51.2M Q2 '16: 34.5M Q2 '13 Q4 '13 Q2 '14 Q4 '14 Q2 '15 Q4 '15 Q2 '16

Operating Cash Flow TTM

-105M -70M -35M 0 35M 70M 105M Q3 '12: -9.6M Q4 '12: -16.5M Q1 '13: -18.6M Q2 '17: -25.7M Q3 '17: -19.5M Q4 '17: -15.2M Q1 '18: -21.5M Q2 '18: -12.7M Q3 '18: -13.5M Q4 '18: -14.5M Q1 '19: -8.6M Q2 '19: -16M Q3 '19: -15M Q4 '19: -13.1M Q1 '20: -11.6M Q2 '20: -11.8M Q3 '20: -16.8M Q4 '20: -23.8M Q1 '21: -37.1M Q2 '21: -49.8M Q3 '21: -54.8M Q4 '21: -59.8M Q1 '22: -68.4M Q2 '22: -81.1M Q3 '22: -81.4M Q4 '22: -94.8M Q1 '23: -94.1M Q2 '23: -85.7M Q3 '23: -86.1M Q4 '23: -70.5M Q1 '24: -67.2M Q2 '24: -61.7M Q3 '24: -50.9M Q4 '24: -44.8M Q1 '25: -33.2M Q2 '25: -37.1M Q3 '25: -30.3M Q4 '25: 7.7M Q1 '26: 15.3M Q2 '26: 34M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-120M -80M -40M 0 40M 80M 120M Q2 '12: -10.3M Q3 '12: -10.3M Q4 '12: -17.4M Q1 '13: -19.4M Q4 '17: -15.3M Q1 '18: -21.7M Q2 '18: -13M Q3 '18: -14.1M Q4 '18: -15.3M Q1 '19: -9.7M Q2 '19: -17.1M Q3 '19: -16M Q4 '19: -13.9M Q1 '20: -11.9M Q2 '20: -12M Q3 '20: -17.1M Q4 '20: -25M Q1 '21: -39M Q2 '21: -53.8M Q3 '21: -59.8M Q4 '21: -65M Q1 '22: -74.2M Q2 '22: -87.1M Q3 '22: -88.2M Q4 '22: -104.4M Q1 '23: -103.6M Q2 '23: -93.3M Q3 '23: -92M Q4 '24: -45.3M Q1 '25: -33.7M Q2 '25: -37.2M Q3 '25: -30.5M Q4 '25: 7.6M Q1 '26: 14.8M Q2 '26: 33.4M Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 90M 180M 270M Q3 '11: 42.4M Q4 '11: 22.7M Q1 '12: 22.7M Q2 '12: 42.7K Q3 '12: 22.8M Q4 '12: 28.4M Q1 '13: 28.2M Q3 '13: 28.3M Q4 '13: 28.3M Q1 '14: 34.3M Q3 '14: 35M Q4 '14: 35.1M Q1 '15: 35.1M Q3 '15: 38.6M Q4 '15: 38.6M Q1 '16: 38.6M Q3 '16: 38.6M Q4 '16: 38.6M Q1 '17: 135.7K Q3 '17: 38.6M Q4 '17: 38.6M Q1 '18: 5.3M Q1 '19: 7.3M Q1 '21: 115.4M Q2 '21: 120.9M Q3 '21: 124M Q1 '22: 125.8M Q2 '22: 126.4M Q3 '22: 126.9M Q1 '23: 135.2M Q2 '23: 139.6M Q3 '23: 152M Q1 '24: 168.8M Q2 '24: 184.7M Q3 '24: 227.5M Q1 '25: 227.9M Q2 '25: 228.4M Q3 '25: 228.9M Q1 '26: 242.2M Q2 '26: 242.2M Q3 '12 Q1 '14 Q4 '15 Q3 '17 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-30.00 -20.00 -10.00 0.00 10.00 20.00 30.00 Q3 '16: -0.75 Q4 '16: -0.82 Q1 '17: -26.52 Q2 '17: -26.49 Q3 '17: -26.37 Q4 '17: -26.22 Q1 '18: 0.11 Q2 '18: -0.98 Q3 '18: -1.76 Q4 '18: -2.36 Q1 '19: -3.03 Q2 '19: -2.18 Q3 '19: -1.58 Q4 '19: -1.02 Q1 '20: -0.86 Q2 '20: -0.59 Q3 '20: -0.35 Q4 '20: -0.35 Q1 '21: -0.47 Q2 '21: -0.48 Q3 '21: -0.54 Q4 '21: -0.58 Q1 '22: -0.64 Q2 '22: -0.74 Q3 '22: -0.83 Q4 '22: -0.84 Q1 '23: -0.83 Q2 '23: -0.76 Q3 '23: -0.64 Q4 '23: -0.58 Q1 '24: -0.53 Q2 '24: -0.46 Q3 '24: -0.41 Q4 '24: -0.34 Q1 '25: -0.27 Q2 '25: -0.25 Q3 '25: -0.23 Q4 '25: 0.07 Q1 '26: 0.16 Q2 '26: 0.17 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.